299 related articles for article (PubMed ID: 28836972)
1. Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study.
Kibirige D; Atuhe D; Kampiire L; Kiggundu DS; Donggo P; Nabbaale J; Mwebaze RM; Kalyesubula R; Lumu W
Int J Equity Health; 2017 Aug; 16(1):154. PubMed ID: 28836972
[TBL] [Abstract][Full Text] [Related]
2. Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective.
Kibirige D; Kampiire L; Atuhe D; Mwebaze R; Katagira W; Muttamba W; Nantanda R; Worodria W; Kirenga B
BMC Pulm Med; 2017 Dec; 17(1):179. PubMed ID: 29216852
[TBL] [Abstract][Full Text] [Related]
3. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
4. Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon.
Jingi AM; Noubiap JJ; Ewane Onana A; Nansseu JR; Wang B; Kingue S; Kengne AP
PLoS One; 2014; 9(11):e111812. PubMed ID: 25369455
[TBL] [Abstract][Full Text] [Related]
5. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
[TBL] [Abstract][Full Text] [Related]
6. Availability, cost and affordability of essential cardiovascular disease medicines in the south west region of Cameroon: Preliminary findings from the Cameroon science for disease study.
Dzudie A; Njume E; Abanda M; Aminde L; Hamadou B; Dzekem B; Azabji M; Doualla MS; Ngowe M; Kengne AP
PLoS One; 2020; 15(3):e0229307. PubMed ID: 32130252
[TBL] [Abstract][Full Text] [Related]
7. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
Chow CK; Ramasundarahettige C; Hu W; AlHabib KF; Avezum A; Cheng X; Chifamba J; Dagenais G; Dans A; Egbujie BA; Gupta R; Iqbal R; Ismail N; Keskinler MV; Khatib R; Kruger L; Kumar R; Lanas F; Lear S; Lopez-Jaramillo P; McKee M; Mohammadifard N; Mohan V; Mony P; Orlandini A; Rosengren A; Vijayakumar K; Wei L; Yeates K; Yusoff K; Yusuf R; Yusufali A; Zatonska K; Zhou Y; Islam S; Corsi D; Rangarajan S; Teo K; Gerstein HC; Yusuf S;
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):798-808. PubMed ID: 30170949
[TBL] [Abstract][Full Text] [Related]
8. Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal.
Sharma A; Kaplan WA; Satheesh G; Poudyal IP; Gyawali P; Neupane D; Bhandari PM; Malla M; Sapkota S; Mishra SR
Glob Heart; 2021 May; 16(1):38. PubMed ID: 34040951
[TBL] [Abstract][Full Text] [Related]
9. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
Sado E; Sufa A
BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
[TBL] [Abstract][Full Text] [Related]
10. Access to essential medicines for diabetes care: availability, price, and affordability in central Ethiopia.
Deressa HD; Abuye H; Adinew A; Ali MK; Kebede T; Habte BM
Glob Health Res Policy; 2024 Apr; 9(1):12. PubMed ID: 38584277
[TBL] [Abstract][Full Text] [Related]
11. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
Osuafor NG; Ukwe CV; Okonta M
PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
[TBL] [Abstract][Full Text] [Related]
13. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
Mendis S; Fukino K; Cameron A; Laing R; Filipe A; Khatib O; Leowski J; Ewen M
Bull World Health Organ; 2007 Apr; 85(4):279-88. PubMed ID: 17546309
[TBL] [Abstract][Full Text] [Related]
14. Trends in access to anti-malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first-line anti-malarials and diagnostics between 2007 and 2018.
Kibira D; Ssebagereka A; van den Ham HA; Opigo J; Katamba H; Seru M; Reed T; Leufkens HG; Mantel-Teeuwisse AK
Malar J; 2021 Mar; 20(1):142. PubMed ID: 33691704
[TBL] [Abstract][Full Text] [Related]
15. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
[TBL] [Abstract][Full Text] [Related]
16. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria.
Orubu ESF; Robert FO; Samuel M; Megbule D
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074
[TBL] [Abstract][Full Text] [Related]
17. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
18. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
[TBL] [Abstract][Full Text] [Related]
19. Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology.
Saeed A; Saeed F; Saeed H; Saleem Z; Yang C; Chang J; Jiang M; Zhao M; Saqlain M; Ji W; Aziz MM; Lambojon K; Gillani AH; Hayat K; Gul S; Fang Y; Babar ZU
Front Pharmacol; 2020; 11():595008. PubMed ID: 33708114
[No Abstract] [Full Text] [Related]
20. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
